ANTH:Anthera Pharmaceuticals Inc - Stock Quote and Dividend Data
LATEST CLOSE PRICE
$0.04
EXCHANGE
OTCBB
SECTOR
Health Care
ANTH
Anthera Pharmaceuticals Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
ANTH
Anthera Pharmaceuticals Inc Stock Information
Latest Close Price$0.04
52-Week Low/High$0.01 - $2.97
Percent Held by Institutions5.35%
Revenue$0
Net Income$-31,115,000
Cash Flow$-9,381,000
EPS-0.42%
Market Cap$1,177,793
52-Week Low/High$0.01 - $2.97
Percent Held by Institutions5.35%
Revenue$0
Net Income$-31,115,000
Cash Flow$-9,381,000
EPS-0.42%
Market Cap$1,177,793
PE Ratio0
PE Ratio to Industry65%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.39%
Total Return Last 12 Months-97.00%
Total Return Last 3 Years-99.88%
Total Return Last 5 Years-99.81%
Latest Trade DateDec. 13, 2018
PE Ratio to Industry65%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.39%
Total Return Last 12 Months-97.00%
Total Return Last 3 Years-99.88%
Total Return Last 5 Years-99.81%
Latest Trade DateDec. 13, 2018
ANTH
Anthera Pharmaceuticals Inc Dividend Payment History
No Data available for Payment History.
ANTH
Anthera Pharmaceuticals Inc Other Details
Anthera Pharmaceuticals is a biopharmaceutical company focused on advancing the development and commercialization of medicines that benefit patients with medical needs. Co. has two compounds in development, Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy intended for the treatment of patients with Exocrine Pancreatic Insufficiency, often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy.
Web Sitewww.anthera.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools
Try Dividend Investor PREMIUM for as low as $29
- Dividend Allstars™ Tool
- Proprietary Ex-dividend Calendar
- Dividend Scorecard™ Portfolio Tracker
- Customized Dividend Stock Screener
- 4 FREE special reports from leading dividend experts
- And much more...
Anthera Pharmaceuticals Inc Dividend Stock News and Updates
Dec. 14, 2018CLOSE PRICE INCREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 12-14-2018 increased close price > 10% from $0.04 to $0.04
Read more...Dec. 13, 2018CLOSE PRICE DECREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 12-13-2018 decreased close price > 10% from $0.05 to $0.04
Read more...Dec. 11, 2018CLOSE PRICE INCREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 12-11-2018 increased close price > 10% from $0.04 to $0.05
Read more...Biotechnology Dividend Stock News and Updates
Dec. 14, 2018CLOSE PRICE INCREASE: Affymax Inc (OTCBB: AFFY) on 12-14-2018 increased close price > 10% from $0.01 to $0.02
Read more...Dec. 14, 2018CLOSE PRICE DECREASE: CTD Holdings Inc (FL) (OTCBB: CTDH) on 12-14-2018 decreased close price > 10% from $0.95 to $0.83
Read more...Dec. 14, 2018CLOSE PRICE INCREASE: Cytori Therapeutics Inc (NASDAQ: CYTXW) on 12-14-2018 increased close price > 10% from $0.00 to $0.00
Read more...
Dividend Income Expert Bryan Perry